Fesoterodine Fumarate 16262-0002-01
- Manufacturer
- Aesica Pharmaceuticals Gmbh
- Dosage Form
- Tablet, Extended Release
- Product Type
- Drug For Further Processing
- Marketing Start
- October 31, 2008
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fesoterodine Fumarate | 8 mg/1 |
Selected Package
16262-0002-01Selected1 BAG in 1 PAIL (16262-002-01) / 31250 TABLET, EXTENDED RELEASE in 1 BAG